
Charles River Laboratories International, Inc.
NYSE:CRL
144.7 (USD) • At close June 6, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Charles River Laboratories International, Inc. |
Symbool | CRL |
Munteenheid | USD |
Prijs | 144.7 |
Beurswaarde | 7,107,041,790 |
Dividendpercentage | 0% |
52-weken bereik | 91.86 - 254.15 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. James C. Foster J.D. |
Website | https://www.criver.com |
An error occurred while fetching data.
Over Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)